Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...

Mayor Wu’s first ever State of the Schools address showcased progress made by the district, while emphasizing there is more work to be done. In a moment when public education is being undermined by ...

China may be taking the lead in the AI race, with open-weight models leapfrogging proprietary ones. A new disruptor, Kimi K2 ...

The Doodle shows how the parabola changes with different numbers, making learning math fun and interactive for students.,, ...

Tylah Tully looks at Vertex Minerals and its growing high-grade gold production in the latest episode of Stockhead's Who’s ...

Why get Google Cloud Generative AI Certified? Over the past few months, I’ve been helping IT professionals adapt to the rapid growth of artificial intelligence. The goal? Getting software professional ...

Drug stocks dominate: Billionaire-led hedge funds tilt their healthcare investments toward large, proven pharmaceutical companies. Eye for innovation: Niche biotech and innovative medical technology ...